We reported that glucagon and phenylephrine decrease hepatocyte GSH by inhibiting -t-glutamylcysteine synthetase (GCS), the rate-limiting enzyme in GSH synthesis (Lu, S. C., J. Kuhlenkamp, C. Garcia-Ruiz, and N. Kaplowitz. 1991. J. Clin. Invest. 88:260-269). In contrast, we have found that insulin (In, 1 jig/ml) and hydrocortisone (HC, 50 nM) increased GSH of cultured hepatocytes up to 50-70% (earliest significant change at 6 h) with either methionine or cystine alone as the sole sulfur amino acid in the medium. The effect of In occurred independent of glucose concentration in the medium. Changes in steady-state cellular cysteine levels, cell volume, GSH efilux, or expression of y-glutamyl transpeptidase were excluded as possible mechanisms. Both hormones are known to induce cystine/glutamate transport, but this was excluded as the predominant mechanism since the induction in cystine uptake required a lag period of > 6 h, and the increase in cell GSH still occurred when cystine uptake was blocked. Assay of GSH synthesis in extracts of detergent-treated cells revealed that In and HC increased the activity of GCS by 45-65% (earliest significant change at 4 h) but not GSH synthetase. In and HC treatment increased the V.. of GCS by 31-43% with no change in K,.
Introduction
Hepatic GSH plays a vital defensive role against toxins and free radicals, and in the storage and transfer of cysteine ( 1, 2) . The synthesis ofGSH from its constituent amino acids involves two ATP-requiring enzymatic steps: the formation of y-glutamylcysteine from glutamate and cysteine, and formation of GSH from 'y-glutamylcysteine and glycine. The first step of GSH biosynthesis is rate-limiting and catalyzed by y-glutamylcysteine synthetase (GCS) ' which is regulated physiologically by feedback competitive inhibition by GSH and the availability of cysteine (1, 3, 4) . We have recently demonstrated that the synthesis of hepatic GSH is also regulated by various hormones. Specifically, cAMP, Ca2+, and C-kinase-dependent hormones downregulate hepatic GSH synthesis acutely by inhibiting GCS, presumably through enzyme phosphorylation (5) . The possibility of hormone-mediated upregulation of hepatic GSH synthesis has not been explored. We examined insulin (In) and hydrocortisone (HC) since they are commonly used as growth factors in culturing hepatocytes but their effects on GSH are unknown. We found that both In and HC increase hepatocyte GSH. This report delineated the mechanisms of their stimulatory effects and demonstrated the physiologic importance ofthese hormones in hepatic GSH homeostasis using in vivo models.
Methods
Materials GSH, collagenase (type IV), BSA, L-methionine, L-cysteine, L-cystine, DTT, diethyl maleate (DEM), NADPH, 5,5'-dithiobis(2-nitrobenzoic acid), sodium EDTA, GSH reductase, hydrocortisone, insulin, glutathione-S-transferases, dexamethasone, streptozotocin, digitonin, fetal bovine serum (FBS), a-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (acivicin), cycloheximide, actinomycin D, and Hepes were purchased from Sigma Chemical Co. (St. Louis, MO). DL-Buthionine-S-R-sulfoximine was obtained from Schweizerhall (South Plainfield, NJ). DME/F12 medium was purchased from Gibco Laboratories (Grand Island, NY). Sulfur amino acid-free (SAF) DME/F12 medium was custom made by Irvine Scientific (Santa Ana, CA). DME low glucose ( 1,000 mg/liter) was from Irvine Scientific. Monochlorobimane was purchased from Molecular Probes, Inc. (Eugene, OR).
-y-(bis) Glutamylcysteine was prepared by enzymatic hydrolysis ofoxidized glutathione (6) and reduced with DTT before use. The purity of y-(bis) glutamylcystine was confirmed by HPLC. L-[33SImethionine ( 1, 120 Ci/mmol) and L-[35S]cystine ( 193 mCi/mmol) were obtained from Amersham Corp. (Arlington Heights, IL). All other reagents were of analytical grade and were obtained from commercial sources.
Animals
Male Sprague-Dawley rats (Harlan Laboratory Animals, Inc., Indianapolis, IN), weighing 260-320 g for preparation of cell cultures and in vivo experiments, were maintained on Purina rodent chow (Ralston Purina Co., St. Louis, MO) and water ad fib. Adrenalectomized rats received 0.9% NaCl instead of water.
Cell culture preparation
Isolation of hepatocytes was done aseptically according to the method of Moldeus et al. (7) . Initial cell viability was 2 85% as determined by 0.2% trypan blue exclusion. For most experiments, the plating medium was DME/F12, high glucose (3,151 mg/liter), containing 10% FBS, and supplemented with excess methionine (1 mM). For experiments designed to examine the effects of sulfur amino acid precursors, SAF medium supplemented with either methionine ( 1 mM) or cystine (0.5 mM) was used instead of DME/F12 as plating medium. 1.5-2 X 106 cells in 5-ml plating medium were plated on 60 x 15-mm dishes precoated with rat tail collagen, incubated at 370C in 5% C02, 95% air. 2-3 h after plating, medium was changed to omit serum and to remove dead, unattached cells. Cell attachment averaged -50%. The continued exposure to serum led to decreased cell GSH, an effect which was not further studied.
Measurement ofGSH and cysteine
Cultured cells were detached by trypsin-EDTA (0.05%, 0.02%, respectively). Cultured cells, liver homogenates, or liver cytosols were treated with 10% trichloroacetic acid to extract cellular GSH. The mixture was centrifuged at 13,000 g in a microfuge (Beckman Instruments, Inc., Palo Alto, CA) for 1 min to remove the denatured proteins and GSH was measured in the supernatant by the recycling method ofTietze (8) .
To measure cysteine concentrations from cultured hepatocytes, cells ( 106) were collected by detaching cells with trypsin-EDTA, and centrifuged in a microfuge for 30 s to remove the trypsin-EDTA solution. Cells were then treated with 5% perchloric acid to precipitate the proteins, centrifuged for 1 min in a microfuge, and supernatant cysteine levels were determined according to the method ofGaitonde (9) . Cysteine levels were measured in liver homogenates according to the method of Gaitonde (9) .
Measurement ofenzyme activities ofGSH synthesis using monochlorobimane Monochlorobimane (mBCl) can be used to measure activities of enzymes involved in GSH synthesis (5, 10) . Briefly, mBCl forms a fluorescent adduct with GSH in a reaction catalyzed by GSH S-transferase. GSH synthesis rates measured by the rate of adduct formation fluorimetrically agree with synthesis rates determined by the method of Tietze (10) .
To measure GCS and GSH synthetase activities in cultured hepatocytes, cells were first incubated in DME/F12 medium supplemented with In (1 Ag/ml) or HC (50 nM) or vehicle for various time periods.
Some plates from each condition were used for cell GSH measurement by the method ofTietze (8) Digitonin-treated cell-free protein extract was obtained by pooling scraped cells from several plates and centrifuging at 1,500 g for 20 min.
The cell-free extract gave similar glutathione S-transferase activity ( 11 ) as compared to 10% Triton-treated cells (data not shown), thus confirming presence of all cytosolic components in the extract.
The cytosol fraction of rat liver was obtained by centrifuging the homogenate (33% wt/vol in 0.01 M sodium phosphate, 0.25 M sucrose, pH 7.4) at 100,000 g for 60 min. To decrease the GSH present, cytosol was dialyzed overnight using molecularporous membrane tubing (mol wt cutoff: 12,000-14,000; Spectrum Medical Industries, Inc., Los Angeles, CA) in 100X vol of 0.01 M sodium phosphate, pH 7.4. After overnight dialysis, cytosolic GSH concentration was decreased by 99-99.5%.
The GSH synthesis rate was measured in cell-free conditions by adding digitonin-treated cultured cell extract ( 1-2 mg protein as measured by assay; Bio-Rad Laboratories, Richmond, CA) or liver cytosol (2-3.5 mg protein) to the cuvette containing: 100 mM Tris-HCI, 150 mM KCI, 20 mM MgCl2, 2 mM EDTA pH 7.3, glutamate (10 mM), glycine (10 mM), ATP (3 mM), cysteine + DTT (0.025-0.5 mM) plus 100 MM mBCl in a final volume of 2.5ml at 370C. The difference in initial rate of linear increase in fluorescence over 6-8 min with or without pretreatment with buthionine sulfoximine (5 mM for 5 min at 370C) is equivalent to the rate ofGSH synthesis. The change in fluorescence is converted to GSH concentration units by using standard curves. Specifically, formation of fluorescent adducts was monitored by adding mBCI ( 100MgM) and glutathione S-transferase (0.1 U/ml) to the cuvette containing GSH standards. Standard curves were then generated by applying linear regression to the relationship between fluorescence and GSH concentration. This method assesses the formation of GSH as an end product from two steps: the formation of'y-glutamylcysteine from cysteine and glutamate (catalyzed by GCS) and the formation of GSH from 'y-glutamylcysteine and glycine (catalyzed by GSH synthetase). To assess only the second step in GSH synthesis, cultured cell extract or liver cytosol was added to the cuvette containing 100 mM Tris-HCI, 150 mM KC1, 2 mM EDTA, pH 7.3, substrates 'y-glutamylcysteine + DTT (0.2 mM), glycine (10 mM), cofactors ATP (3 mM) and Mg2" (20 mM) , plus 100MuM mBCl in a final vol of 2.5 ml at 37°C. The difference in initial rate oflinear increase in fluorescence over 8-10 min in the presence of all precursors and cofactors for the second step of GSH synthesis versus only 'y-glutamylcysteine + DTT is equivalent to the rate of GSH synthesis catalyzed by GSH synthetase.
Uptake of methionine and cystine by cultured rat hepatocytes Cultured hepatocytes were plated in DME/F12 containing high glucose, 10% FBS, and excess methionine (1 mM). 2 h after plating medium was changed to omit FBS and In (1 ug/ml) or HC (50 nM) or vehicle was added. Most uptake studies were done 16 h after this medium change. For shorter time incubations, medium was changed to control medium (no FBS, In, or HC) 2 h after plating. 16 h after plating medium was changed to that supplemented with hormone or vehicle.
Uptake studies were carried out 6 h after this second medium change.
The technique used for measuring sulfur amino acid uptake was adapted from Takada and Bannai ( 12) . The medium used for washing and stopping uptake was 10 mM PBS, pH 7.4, with 0.01% CaCl2, 0.01% MgCl2.6H20, and 0.1% glucose. Transport medium was the same medium supplemented with nonradioactive methionine ( 1 mM) and cystine (0.18 mM) to simulate the concentrations present in the culture medium (DME/F12, supplemented with 1 mM methionine). Cultured cells were washed twice (2 ml each) with prewarmed buffer and transport was initiated by addition of 1.5 ml transport medium containing either 35S-methionine (0.5-1.0 MCi) or 35-cystine (0.17 ,MCi). After incubation at 37°C for the required time, uptake was terminated by washing five times (2 ml each) with ice-cold wash buffer. The number ofwashes was determined by counting dpm in the supernatant after each wash. After four, five, and six washes, 0.02%, 0.004%, and 0.001% of total dpm was recovered in the supernatant, respectively. Cells were then dissolved with 0.5 ml of 0.5 N NaOH; an aliquot was used for determining the radioactivity and another for protein assay. To estimate trapping, uptake at 4°C (on ice) was studied in parallel. Duplicate plates were used for each time point and condition. The To evaluate the effect of glucose concentration in the medium on the In-mediated increase in cell GSH, cells were plated in DME medium containing low glucose (1,000 mg/ liter) or high glucose (3,151 mg/liter) with or without In (1 ,tg/ml). Cell ( 13) . Thus, although the GSH efflux rates were higher, they were appropriate for the cell GSH level.
Increased cysteine availability can occur by increased transport of sulfur amino acid precursors, which in the case of cultured hepatocytes would be methionine and cystine since almost all cysteine is autoxidized to cystine in culture media ( 14, 15) . Both In and HC have been shown to increase cystine/glutamate uptake (xc-system) in cultured hepatocytes ( 12) . Uptake of methionine was rapid and linear over 1 min whereas uptake ofcystine was much slower and remained linear over 10 min (data not shown). Subsequent uptake studies were performed by measuring the uptake value at 40 s for methionine and 5 min for cystine. Fig. 2 shows uptake of methionine and cystine with or without hormone treatment. Methionine uptake was not influenced by the addition of In or HC. Cystine uptake was significantly increased by In or HC treatment. This increase in cystine uptake was glutamate (2.5 mM)-inhibitable as previously described ( 12) and required a lag period of> 6 h. Therefore, the increase in cell GSH at 6 h for both In and HC cannot be explained by increased cystine uptake. To see ifthe increase in cystine uptake could be responsible for the increase in cell GSH after overnight treatment with In or HC, effects of the hormones were exar-ned using SAF media supplemented with either 1 mM met iionine or 0.5 mM cystine and sufficient glutamate (2.5 mM) to block the entry of cystine. This point was confirmed by measuring cystine uptake after cultured hepatocytes were incubated with In or HC or vehicle with or without glutamate (2.5 mM) overnight (data not shown). Fig. 3 shows that both hormones significantly increased cell GSH regardless of the type of sulfur amino acid precursor present in media. Inhibiting cystine uptake did not abolish the stimulatory effects of In and HC on cell GSH when media contained methionine. Therefore, this excludes the possibility that methionine conversion to cysteine intracellularly leads to liberation of cysteine into the medium with its accumulation as cystine which is then available for reuptake by an induced cystine transporter. As expected, glutamate treatment lowered the cell GSH when media contained only cystine verifying the efficacy of glutamate in inhibiting cystine uptake. Thus, hormone-induced amino acid transport cannot explain To see if increases in GSH synthetic enzyme activities may be responsible for the increase in cell GSH, we measured enzyme activities in digitonin extracts after hormone treatment of cultured cells for variable periods. Table II shows that cell GSH levels were significantly increased after 16 h incubation with In ( 1 gtg/ml) or HC (50 nM), and depleted to 1 1-13% of original values after 30 min of DEM (0.3 mM) treatment. GSH synthesis rates from substrates for both steps in GSH synthesis (cysteine 0.1 mM, ATP 3 mM, glutamate 10 mM, and glycine 10 mM) were increased by 45-65% after treatment ofcultured cells with In or HC. In contrast, GSH synthesis rates from substrates for the second step in GSH synthesis (z--glutamylcysteine 0.2 mM, glycine 10 mM, ATP 3 mM, and Mg2+)
were not significantly different among the three groups. This increase in GCS activity was evident after 4 h of incubation with Ii or HC (control, 0.34±0.05; In, 0.66±0.11; HC, 0.56±0.11 nmol GSH synthesized/mg per min; results are expressed as mean ± SE from four cell preps, both In and HC are significantly different from controls at P < 0.05 by paired t test) but not after 2 h (control, 0.32±0.05; In, 0.33±0.02; HC, 0.31±0.05 nmol/mg per min; n = 3). The amount of protein in the cell-free extract per 106 cells were similar in the three groups. It should be noted that the protein extracts contained cytosol and other solubilized cell constituents. Thus the specific enzyme activities of GCS in these extracts are lower than that of cytosol due to the presence of a greater fraction of total cellular protein in the digitonin extracts.
To ascertain whether In and HC treatment affect the Km or V,.,, or both of GCS, GSH synthesis rates in cell-free protein extracts were measured while increasing the concentration of cysteine from 0.025 to 0.5 mM. Fig. 4 Results are expressed as mean±SE from five to nine cell preps (n = 9 for GSH synthesis measurement from both steps, n = 5 for GSH synthesis measurement from second step only). Cultured hepatocytes were incubated with In (1 gg/ml) or HC (50 nM) for 16 h. For each condition, cell GSH was measured before and after 30 min of DEM (0.3 mM) treatment. GSH synthesis rates were measured in digitonin-treated cell-free protein extracts fluorometrically with mBCl (see Methods). * P < 0.01; * P < 0.05 vs. control by paired Student's t test.
Effects ofremoval ofinsulin and glucocorticoids on hepatic GSH metabolism in vivo. We next investigated the influences ofinsulin orglucocorticoid deficiency on hepatic GSH metabolism in vivo. We used streptozotocin (STZ)-induced diabetic or bilaterally ADX rats as our in vivo models of insulin or glucocorticoid deficiency, respectively (16, 17) . Tables IV and  V show that STZ-treated diabetic and ADX rats exhibited lower hepatic GSH levels as well as GCS activities than respective controls. On the other hand, activity of GSH synthetase (GSH synthesis rates from y-glutamylcysteine and glycine) was unaffected by these treatments (controls for diabetic rats: 7.73±0.37; STZ, 7.65±0.72; sham-operated controls for ADX rats, 7.76+0.51; ADX, 7.83±0.32 nmol/mg per min). Cysteine levels were also unaffected by these treatments. Both the decreased hepatic GSH levels and GCS activities were pre- . These values are within the normal range reported (18) . This excludes significant dehydration in these animals. 
Discussion
Hepatic GSH is vital for defense against toxins and interorgan homeostasis of GSH. The synthesis of hepatic GSH is a key step in the process and our work has been aimed at understanding its regulation. We began the present studies by investigating the influence of In and HC on GSH levels in cultured hepatocytes. We chose to examine these two hormones because of their known importance in regulation of numerous proteins and enzymes in hepatocytes (19) (20) (21) (22) (23) (24) (25) (26) . We observed that the lowest doses of In and HC which increased GSH were in the known physiologic range ofeach hormone (27, 28). Thus, it is possible that physiologic changes in In and HC regulate GSH synthesis. However, detailed in vivo studies will be required to prove this hypothesis. Ofimportance, the effect ofIn on stimulation ofcell GSH occurred independent ofthe glucose concentration in the medium. Thus, it is unlikely that "hyperglycemia" alone had a negative impact on GSH synthesis which was corrected with In. Furthermore, hepatic GSH and GCS activities were lower in the ADX rats despite no change in serum glucose levels from sham controls. Many factors can potentially influence steady-state cell GSH levels. We therefore set out to systematically examine these to define the mechanism(s) accounting for the In-and HC-induced increases in hepatocyte GSH. A number offactors were excluded, namely, changes in cell volume, GSH efflux, and expression of 'y-glutamyl transpeptidase. The two remaining major possibilities were then studied in detail: availability of cysteine and activities of GSH synthetic enzymes.
Availability ofcysteine can be increased in cultured hepatocytes by increased uptake ofsulfur amino acids, namely, methionine and cystine, increased activity of transsulfuration pathway, or decreased activity of cysteine catabolic pathways. The increase in cell GSH induced by In or HC occurred when only methionine or cystine was the sole source ofsulfur amino acid, and as early as 6 h after hormone treatment. Methionine uptake was unaffected by In or HC. Increased activity of transsulfuration also could not account for the increase in cell GSH since it occurred with cystine alone. In contrast to methionine, cystine transport is known to be induced by In and glucocorticoids in culture ( 12) . We confirmed this finding. However, we could dissociate the increase in cell GSH from the increase in cystine uptake in time course studies; the former preceded the latter. These results do not exclude a contributory role for induction of cystine transport in increasing cell GSH (especially at the 16 h time point) but demonstrate that another mechanism makes a major contribution.
The other mechanism we considered was increase in GSH synthetic enzymes. Both In and HC increased the activity of GCS but not GSH synthetase. Kinetic tion of the GCS mRNA, or decreased degradation (stabilization) of GCS. The inhibition by actinomycin D favors the former. However, further work at the molecular level will be required to delineate the mechanisms of In and HC. The simplest in vivo counterpart to the induction of GCS by In and HC in cell culture is to examine the influence of deficiency ofthese hormones on hepatic GSH and GCS as well as the effect of replacement of the respective deficient hormone. Indeed, both STZ-induced diabetic rats and ADX rats exhibited lower hepatic GSH levels and specific activities of GCS in hepatic cytosol compared to controls. Both effects were reversed by hormone replacement which excludes other mechanisms for the changes related to the STZ or surgery rather than hormone deficiency. The specific activities of GSH synthetase were unaffected by STZ or adrenalectomy. The magnitude of fall in liver GSH level did not correlate with GCS activity in the two in vivo models (diabetic rats had more profound fall in GCS activity but less fall in liver GSH level in comparison to the ADX untreated rats). This points to the complexities of in vivo models, so that other factors probably contribute to these differences. For example, ADX rats may have been more "stressed" and had increased sinusoidal GSH effilux and hence much lower hepatic GSH levels ( 13) ; or hormones such as glucagon (which may be increased in diabetes) may further downregulate GCS activity in untreated diabetic rats (5) . Regardless of other factors that may have been involved, deficiency of In or glucocorticoids was associated with decreased GCS which undoubtedly played a contributory role in the fall in hepatic GSH and appropriate replacement of the hormones corrected the abnormalities.
When calculations are made to compare the GCS specific activities ofcultured cells to that ofliver cytosols from diabetic or ADX rats with or without hormonal replacement (based on 108 hepatocytes per gram liver), the results are in close agreement. Thus, the hormone-deficient cultured hepatocyte model closely mimics the in vivo deficiency models. In and HC play an important role in the basal maintenance of hepatic GSH indicating hormone dependence. As noted above, it remains to be seen if changes in these hormones within the physiologic range exert a regulatory role.
There are conflicting data in the literature regarding the effect of diabetes on hepatic GSH levels (29, 30) . Loven and colleagues reported lower hepatic GSH concentration in diabetic rats (29) which was corrected with insulin replacement. No mechanism was provided in their work, however. McLennan et al. on the other hand, did not find lower hepatic GSH level in diabetic rats but reported significantly increased hepatic y-glutamyl trans-peptidase activity (30) . This resulted in almost undetectable canalicular GSH efflux, presumably due to increased breakdown ofGSH. This in fact may have masked a lower hepatic GSH since the increased activity ofthe hepatic 'y-glutamyl cycle could increase the availability of cysteine for GSH synthesis by its reuptake in the canaliculus or bile duct (cholehepatic shunting). Our data are in agreement with that ofLoven and colleagues, and suggest that one potential mechanism for lower hepatic GSH levels in untreated diabetic rats is lower hepatic GCS activity. This may have significance concerning the pathophysiology of complications of diabetes mellitus. GSH depletion in erythrocytes and lens have been reported in diabetes and may contribute to increased susceptibility to oxidant stress and cataract formation, respectively (31, 32) . Since the liver is the source of plasma GSH and cysteine ( 1, 2, 33) , decreased capacity for the liver to synthesize GSH may translate into decreased availability of GSH and cysteine to the rest of the body. This may in turn predispose the animal to complications from diminished GSH and sulfhydryls. These possibilities are worthy of further study.
In summary, both insulin and glucocorticoids increased GSH levels in cultured hepatocytes by induction ofGCS activity. The importance of these findings was confirmed using in vivo models. In fact, results from in vivo experiments showed that insulin and glucocorticoids are important in "maintaining" normal hepatic GSH levels and expression of GCS activities.
